College or American Pathologists325 Wallkegan Road Nonhndd IIlinois 60093-2750800-323-4040 hnpwwwealnrg

Advancing Excellence ORIGINAL EVALUATION

C-B 2013 Chemistry

INSTITUTION

ATfENTION

JK I Jaboratoriul11 fur Klinische hlrschllng Cl11bl J

~chTntinCt1tal CE 24223

Volker U-~al11alollli PhD

CAPNUMBER

KIT INFORMATION

723413(-0

KitID25522((3

Kit

Kit Mailcd(32013

Original Evaluation

7X21113

Next Mailing Date

107201)

COPIED TO CP

IllPORTANT NOTES

LEGEND Exception Reason Codes appearing in this evaluationPli = No appropriltc targetresponse cannot be graded12XI = Response CIualificd with a greatlT than oress than sign lInabe 10 lllllIllitate

or7f 2()~ (Date

Thc College of 1111e1C1n Patilolo-rlsts f(COI1l111ltHis thaI t1w [(stllt (Ir this it1fltrbb()raf()r~ cotnpuisoll not hc lIsld lS a sole rritCtOll for ludhrll1g the plrfOnnll1cc or any indi-idual ciintcai bbucl(()f-

O(jO 12360 Page I of 15

C-B 2013

Institution LKF Laboratorium fur Klinische pOr5chung GmbH

Attention Volke ElSamalouci [hD

City State Schwenlnellcal GE 24223eCollege of American Pathologistsbull ~~ 325 Wallk~gn Ruad NonhOcld I1linois 6003275llLlo bull 800313-4040 hUplwwwc[gtorg

- _ J Advancing Excellence

EVALUATIONORIGINAL

CAP N um ber 7234116-01 Kit I Kit ID 25522((3

Kit Mailelt 632013

Original Evaluation 782013

ChemistryEVlluation and Cam Plot ofthe Relative Distancc ofYour Resll nom

Target as Pereentages of 31lowed DeviationTctUnit ofMcasurcPeer Group

SpeeimcnYourResult lean SD

arative Method Stati8tiesNoof Limits of Acceptability

Lab SDI Lower UpperYourGrade Survcy -lOO-------Mc an-------- +100

ALT (SGPT)ULROCHE HIJjCHI SYSTEMSROCl-lE 15-137 C

CHM-06CHM-07CHM-08CHM-09CHMtO

914(8879200

[201

1201[2deg1[20]

120]

rszlig 20DCAOUe-e 2012

10080 60 4() 20 0 20 4ltl 60 80 100

250 25n 094 1(5 08 231 284 Aceeptahle230 2319 099 [63 -02 208 256 lcceptable250 25(2 103 165 06 230 282 Acceptablc320 32 099 1(5 -10 296 363 Acccptablc2R0 2824 0 163 -03 254 311 Accc table112 1200 4 3 159 18 R3 156 Acceptable47 496 19 159 -14 34 (5 Acceptablc c-n 101)

113 1198 42 ISR 16 R3 156 Acceplable C-A20IJ

78 855 31 159 24 59 112 Acceptable ce 2011

271 318R 133 158 -3() 223 415 Acceptable -100 -80 60 -40 10 0 20 4ltl 6Q 80 100

CHM-06CHM07CHM-08CHM-09CHMlOCHM06CHM-07CHM08CHM09CHM-tOCHM06CHM07CHM08CHI09CHM-IO

Alkaline PhosphatascULROCHE MODULARROCI-IE37 C

Methodlnstrumenl

Albumin

gLDYE B1NDINGszligCGROCH E MODULAR

The College orArncncal1 Pathologists reconunends rhat rhe nsult of chis interlflhorarory cornpcison nut hc uscd as sole crltCnon far judging [he pcrfonnaJ1n of an~ indiidul1 c1inical bhoratory

OUUl 12361 Page 2 t~1 15

C-B 2013

Institution 111 Laboratorium fur Klinische lI~ehung (mbll

Attention Volker 1-1-Samaouti PhI)

City State SchwltltinelttaI CI 24223

College of American Pat hologists315 Waukcgall Rnad Nnnhlicld IIlinnis iJOOi3-l750800-Jl3-4040 bull hlt pwwweapnrg

Advancing Excellence

EVALUATIONORIGINAL

CAP Number 72341)(-01 Kit 1 Kit ID 25522((3

Kit Mailed (32111)

Original Evaluation 7 X21l I)

ChemistryPlot of the Relative DistalCe of Your Resllits from

Target as Pcrcentagcs of allowcd Dcdatiol1TestUnit of IleasurePeer Grollp

Amylase serum

ULI~OClIE fIODULR

ROCIIIJ)7 C

AST (SGOT)

ULROClIE fIODULR

ROCIII 1-5-137 C

Bilirubiu direct

mgdLDIAZO (l~OClm) wILlNI

ROCI JE fIODULW

flct hod In~ trumen t

Specimen

CHM-06CHlI-07CHM-08

CHM-09

CHM-lO

CHM-06

CHM-07CHM-08

CHM-09

CHM-IO

CHM-06CHM-07

CHM-08

CHM-09CHM-IO

CHM-06CHM-07CHM-08

CHM-09

CHM-IO

Evaluation and Com arative Method Statistics

Your NOof Limits of Acceptability YourResult Mean SD Labs SDI Lower Upper Grade

1(11) 1015 19 145 -OS 71 1)2 lcclptabk59 591 12 141 -01 41 77 lcclltabk101 IIl 1( 20 14) Il) 71 Iraquo lcclptabllX3 X4( 17 143 -10 59 IIIl lcceptabk212 2149 3X 141 -IIX ISO 2XO cceptabll

11) 1191 41 19 -15 95 143 cclptabk54 571 27 19 -12 45 (J lcclptabk113 IIX3 47 19 11 94 142 lcclptabk94 1009 34 19 -20 XO 122 lcclptabk271 2X4 ) X9 19 -15 227 342 cclptabk

2) 214 1l12 14 +13 17 2( lcccptabk)1 292 1l1( 14 + 11 2 ) 15 lcceptabk2 ) 215 1112 14 + I ) 17 2( cccptable22 2114 014 14 + 12 1( 25 cceptabk0( 052 OUS 14 +1l9 01 IIl lcce )table

Survey

CH2(1)

C- 20-

c-c 2012

en 201)

C-A 2111

CB2013

C- 201 )

CC21112

-100------------ Me an -----------+ 100

__ f-100 -ff) -0 - 40 -20 () 20 40 0 3(1 100

-pound_-100 -30 -ljO -40 ltU (I 20 -ln 00 3() 100

l1ll College of in1t1C3n iatllo1oJ1SS fltCOt11111ends dur he resliit of his illtlr1abora()t~ clllnpltSoll 110 bc lIsnl as a soll critCt()1l for lllllhring the plrfnnnlllCL of lIlY indiidllai clinicd iabocHory

0001 12362

C-B 2013

Institution 111 Laboratorium fur Klinische lI~ehung (mbll

Attention Volker 1-1-Samaouti PhI)

City State SchwltltinelttaI CI 24223

College of American Pat hologists315 Waukcgall Rnad Nnnhlicld IIlinnis iJOOi3-l750800-Jl3-4040 bull hlt pwwweapnrg

Advancing Excellence

EVALUATIONORIGINAL

CAP Number 72341)(-01 Kit 1 Kit ID 25522((3

Kit Mailed (32111)

Original Evaluation 7 X21l I)

ChemistryPlot of the Relative DistalCe of Your Resllits from

Target as Pcrcentagcs of allowcd Dcdatiol1TestUnit of IleasurePeer Grollp

Amylase serum

ULI~OClIE fIODULR

ROCIIIJ)7 C

AST (SGOT)

ULROClIE fIODULR

ROCIII 1-5-137 C

Bilirubiu direct

mgdLDIAZO (l~OClm) wILlNI

ROCI JE fIODULW

flct hod In~ trumen t

Specimen

CHM-06CHlI-07CHM-08

CHM-09

CHM-lO

CHM-06

CHM-07CHM-08

CHM-09

CHM-IO

CHM-06CHM-07

CHM-08

CHM-09CHM-IO

CHM-06CHM-07CHM-08

CHM-09

CHM-IO

Evaluation and Com arative Method Statistics

Your NOof Limits of Acceptability YourResult Mean SD Labs SDI Lower Upper Grade

1(11) 1015 19 145 -OS 71 1)2 lcclptabk59 591 12 141 -01 41 77 lcclltabk101 IIl 1( 20 14) Il) 71 Iraquo lcclptabllX3 X4( 17 143 -10 59 IIIl lcceptabk212 2149 3X 141 -IIX ISO 2XO cceptabll

11) 1191 41 19 -15 95 143 cclptabk54 571 27 19 -12 45 (J lcclptabk113 IIX3 47 19 11 94 142 lcclptabk94 1009 34 19 -20 XO 122 lcclptabk271 2X4 ) X9 19 -15 227 342 cclptabk

2) 214 1l12 14 +13 17 2( lcccptabk)1 292 1l1( 14 + 11 2 ) 15 lcceptabk2 ) 215 1112 14 + I ) 17 2( cccptable22 2114 014 14 + 12 1( 25 cceptabk0( 052 OUS 14 +1l9 01 IIl lcce )table

Survey

CH2(1)

C- 20-

c-c 2012

en 201)

C-A 2111

CB2013

C- 201 )

CC21112

-100------------ Me an -----------+ 100

__ f-100 -ff) -0 - 40 -20 () 20 40 0 3(1 100

-pound_-100 -30 -ljO -40 ltU (I 20 -ln 00 3() 100

l1ll College of in1t1C3n iatllo1oJ1SS fltCOt11111ends dur he resliit of his illtlr1abora()t~ clllnpltSoll 110 bc lIsnl as a soll critCt()1l for lllllhring the plrfnnnlllCL of lIlY indiidllai clinicd iabocHory

0001 12362

C-B 2013

Institution LKF Laboratorium [ur Klinichc Porchung GmbH

Attention Volkcr EI-Samalol1ti PhD

City State SChWtIlWlllllal GE 24223eCollege of American Pathologistsbull ~ 325 Wanke RlIad NlInhneld lllinois 60(9)-2750

U- bull 800323-4010 hlpJwwwclorg

-=~- Advallcing Excellence

EVALUATIONORIGINAL

CAP Numbcr 7234136-01 Kit 1 Kit ID 25522663

Kit Mailed (gt2013

OriginlJ EVlhlation 7R2013

Chcmistry

111CCoHcge of mCr1can PalhnlllSlg rLcommcl1d~ thar tbc nsllr f)f thi- interlahoraro(y comr(ri~on no[ bc uscd lS ~sole cntcnOIl for judgi11g the pcrfnnnmcc of an indi~dutl clinical bhnralOry

Mcthod Mc~n

TestUnit of MeasurePeer Group

EVlluation and Com arative Mcthnd Statistics Plot ofthc Relativc Dirce ofYour Reul front

Your Noof Limits of Acceptability YOllr Target as PercentagcB of allowcd Deviation

Spccimen Resu1t Mean SD Labs SDl Lowcr Uppcr Grade Survcy -lOO----------MclIl--------+ 100

CHM-06CHM-07 CR ~n13 [-l--f-mCHM-08 (-1013

CHM-09(-(012 ------j-- - --- --- -r- -

CHMIO -100-80 ~o -41) -20 0 20 lt0 60 80 100

CHM-06 32 304 016 10 +10 24 37 AcccptablcCHM-07 42 403 021 10 +OR 32 49 AcccptablcCHM-08 32 299 014 10 +15 23 3lt1 AcccptabicCHM-09 32 294 016 10 +16 23 36 AcceptablcCHM-lO 11 094 008 10 +21 05 14 lCCC )tableCHM-06 252 2474 0057 168 +08 222 273 JcccptabicCHM-07 22lt1 2215 O04R 165 +09 1 247 Acceptble (szlig OI3

CHM-OB 251 247( 0053 166 +06 222 273 Acccptablc C 2(1)

CHM-09 185 1837 0046 167 +03 158 209 AcccptabicC( ZOl2

CHM-IO 345 3414 0069 168 +05 316 367 Acccptablc -100 -80 -60 -lt0 -10 0 20 lt0 60 80 100

CHM-06 102 1029 12 173 -08 97 I()lt) JcccptabicCHM-07 108 1091 12 172 -09 103 115 Acccptablc (B lOB [ili~ddCHM-08 101 102R LI 171 -17 97 108 Acceptable (- 2DIJ

CHM-09 114 1143 12 171 -03 108 121 Acceptlblc C-C2fll - ------i - - ------CHM-IO RO 817 1 170 -14 77 8( cccptablc -100l(l 60 40 -20 0 20 01) 10 80 100

123630001

Chloridemmu1L

ION SELECT ELECT DlLROCHE MODULAR

Calcium serummmolLCRESOLIHTI-lALElN corvn)LROCHE MODULtR

Bilimbin totalmgJLDlAZO (ROCHE) VBLANKROCHE MODUL1R

-r=-----------------

College or Amcrican Pathologists325 Waukegan Rualt NlIrthfidd IIhuois 600932750ROO323-l040 hllpwwwcalorg

Advancing Excellence

EVALUATIONORIGINAL

Kit 1

Institution IKJi LabnrlIori1l1l1 rur Klinische liorschllng (mbl[

Attention Volker JoSamaloliti PhD

City State Scl1Hntinental c I ~4~~

C-B 2013

Kit ID ~55~~((J)

Kit l1ailed ()~IIl)

Original Evaluation 7 S~III)

Chemistry

TestUnit of l1easllrePeer Grollp

Cholcsterol

mgtl1NZYflFT[CR()CI W fIODUL1R

Cortisol serum

ugt1IOC] 11diOO SEII170

Creatine Kinase

UR()C1W f[ODUrR

ROCIIE)7 C

Creatinine serum

mg t1LENZYfIXIICROCl [I fIODULJR

Evaluation amI Com arative IIethod Statistics Plot of the Relatie Dislance of Vom Resllits from

Your Noof Limits of Acceptahility YourTarget as Pcrcclltagcs of allowcd Dcytation

Specimen Result IIcan SD Lahs SDI Lowcr Uppcr Grade Survey -100------------l1e an -----------+ 100

CHI1-06 1(110 1(5)() 5~ 1711 IIS 14)37 IR~57 icceptabil

CHI1-07 14~1I11 143S7) 11)) 1() -1)( 1~94) 158~7 icceptabil C-H 2013 1CHI1-08 1(4110 1((0(1 )5S~ 171 0( 14)45 IS~(7 iceeptabil C-- 20L

CHI1-09 ~I~II() ~ 17444 4 ~S 1() 13 1)5() ~WI) icceptableCC2012

CHM-I0 19~IIII 145~ 411(7 170 11 l7(SO ~1(1I1 lcceptabil -1(1( -30 -(( IU 0 ~n ~(l 0 811 100

CHM-06 14) 14~1 1)5~ ~I( + I I()( 17S Fcccptabil

CHI1-07 1~5 1178 1147 ~~(I + 15 SS 14S icceptabil CH 2nu

~CHI1-08 15 14~5 (15~ ~~O +~() Ill(J 17) rcceptabil C- 2U13

CHM-09 ~(7 ~512 IlSII 21) +211 ISS 15 icceptabilce 2012

CHM-lO 15( 1t84 1I51l ~I) + 15 I I I IS( icceptabil -1(1() -2(1 -((1 -4(1 -20 (1 20 4(1 1) 8(1 100

CHI1-06 ~OltJ ~IJ)) (J 15~ +IIS 14~ ~(( icccptabil

CHI1-07 IS7 ISII5 5R 15~ + 11 I~( ~5 Icccptlbil C-B 201

Id 1 ICHI1-08 ~()) ~II)S 57 151 +11) 14~ ~(5 Icccptabil c- 2()13

CHM-09 445 4333 111l 154 + 11 0) 5(4 IcceptabilC-C 2012

CHM-lO 1(1 157 54 1511 +14 11)7 2()() icccptable -Fl(l -80 -(0 40 -20 I) 21) 40 n 8(1 ]00

CHII-06 477 4( I (J (J()8( (d + 18 3~2 531 cceptablc

CHM-07 5 5S3S (J(J)7 (J(J +13 4 (72 icnptabk t-I) 201) bCHM-08 4() 4cJ~1I (JURI (JU +U) -)~ 5~ icceptabk C- 2fJ)

CHM-09 ~75 ~()4 OU55 (d +IU 2~) 3IU Acccptahkce 2012

CHM-IO ~5 ~501 UU4) (d +O(J ~I~ ~SS icceptahk - I(II) -30 -11 -40 _~l(I J 20 4n 11 8(1 1((1

Thc College ()f IllL1lcan Patholofrlsts flClltlltllltH1s thaI the rcslIlt of Ihis it1tefbb()rll()t-~- COtllparislJll l10t be used lS l soll critlLol1 fot judging the pcrfonnanc( flf Il~-ilHIi-ldut1 clinical hbora1flr~

()UUl 12364 Page 5 or 15

-r=-----------------

College or Amcrican Pathologists325 Waukegan Rualt NlIrthfidd IIhuois 600932750ROO323-l040 hllpwwwcalorg

Advancing Excellence

EVALUATIONORIGINAL

Kit 1

Institution IKJi LabnrlIori1l1l1 rur Klinische liorschllng (mbl[

Attention Volker JoSamaloliti PhD

City State Scl1Hntinental c I ~4~~

C-B 2013

Kit ID ~55~~((J)

Kit l1ailed ()~IIl)

Original Evaluation 7 S~III)

Chemistry

TestUnit of l1easllrePeer Grollp

Cholcsterol

mgtl1NZYflFT[CR()CI W fIODUL1R

Cortisol serum

ugt1IOC] 11diOO SEII170

Creatine Kinase

UR()C1W f[ODUrR

ROCIIE)7 C

Creatinine serum

mg t1LENZYfIXIICROCl [I fIODULJR

Evaluation amI Com arative IIethod Statistics Plot of the Relatie Dislance of Vom Resllits from

Your Noof Limits of Acceptahility YourTarget as Pcrcclltagcs of allowcd Dcytation

Specimen Result IIcan SD Lahs SDI Lowcr Uppcr Grade Survey -100------------l1e an -----------+ 100

CHI1-06 1(110 1(5)() 5~ 1711 IIS 14)37 IR~57 icceptabil

CHI1-07 14~1I11 143S7) 11)) 1() -1)( 1~94) 158~7 icceptabil C-H 2013 1CHI1-08 1(4110 1((0(1 )5S~ 171 0( 14)45 IS~(7 iceeptabil C-- 20L

CHI1-09 ~I~II() ~ 17444 4 ~S 1() 13 1)5() ~WI) icceptableCC2012

CHM-I0 19~IIII 145~ 411(7 170 11 l7(SO ~1(1I1 lcceptabil -1(1( -30 -(( IU 0 ~n ~(l 0 811 100

CHM-06 14) 14~1 1)5~ ~I( + I I()( 17S Fcccptabil

CHI1-07 1~5 1178 1147 ~~(I + 15 SS 14S icceptabil CH 2nu

~CHI1-08 15 14~5 (15~ ~~O +~() Ill(J 17) rcceptabil C- 2U13

CHM-09 ~(7 ~512 IlSII 21) +211 ISS 15 icceptabilce 2012

CHM-lO 15( 1t84 1I51l ~I) + 15 I I I IS( icceptabil -1(1() -2(1 -((1 -4(1 -20 (1 20 4(1 1) 8(1 100

CHI1-06 ~OltJ ~IJ)) (J 15~ +IIS 14~ ~(( icccptabil

CHI1-07 IS7 ISII5 5R 15~ + 11 I~( ~5 Icccptlbil C-B 201

Id 1 ICHI1-08 ~()) ~II)S 57 151 +11) 14~ ~(5 Icccptabil c- 2()13

CHM-09 445 4333 111l 154 + 11 0) 5(4 IcceptabilC-C 2012

CHM-lO 1(1 157 54 1511 +14 11)7 2()() icccptable -Fl(l -80 -(0 40 -20 I) 21) 40 n 8(1 ]00

CHII-06 477 4( I (J (J()8( (d + 18 3~2 531 cceptablc

CHM-07 5 5S3S (J(J)7 (J(J +13 4 (72 icnptabk t-I) 201) bCHM-08 4() 4cJ~1I (JURI (JU +U) -)~ 5~ icceptabk C- 2fJ)

CHM-09 ~75 ~()4 OU55 (d +IU 2~) 3IU Acccptahkce 2012

CHM-IO ~5 ~501 UU4) (d +O(J ~I~ ~SS icceptahk - I(II) -30 -11 -40 _~l(I J 20 4n 11 8(1 1((1

Thc College ()f IllL1lcan Patholofrlsts flClltlltllltH1s thaI the rcslIlt of Ihis it1tefbb()rll()t-~- COtllparislJll l10t be used lS l soll critlLol1 fot judging the pcrfonnanc( flf Il~-ilHIi-ldut1 clinical hbora1flr~

()UUl 12364 Page 5 or 15

bull College of Amen Phologists CAP Number 7234136-01 Kit 1 Kit ID 25522663bull ~ 325 WaukegunRulI Nonhfield I1Ilnols6009gt-2750 Institlltion LKF Lahoratorium fur Klinischc rorschung GmbH Kit Mailed 632013

_~ 800323-4040 huplwwwcalorgAttention Volker EI-Samalouti PhD Original Evaluation 7B20 I)

- Advancing Excellence City I State Schcnrincnral GE 24223

EVALUATIONC-B 2013 Chemistry

ORIGINALTe9t Evaluation and Com ararive Method Starisries Plot ofthc Relativc Distanee fYur Resulrs from

Unit of MeaSUTeYour Noof Limits of Acceptability Your Target as Percentages of allowe Deviation

Peer GrollpSpeeimcn Result Mean SD Labs SDI Lower Upper Grade Survey -100---------Mean--------+ 100

Glucose senm CHM-06 1400 14039 313 158 01 1263 1545 Acceplable

mgclL CHM-07 900 900B 19B 158 00 810 991 Acccplable cn 2013 l=Rf~=HJ-IEXuumlKINiSE UV CHM-08 1400 14111 140 161 -03 1269 1513 Acceprablc CA 101

RuumlCHE MuumlDUUR CHM-09 710 7197 176 159 -06 647 792 Acceprable c-c 20lZ

CHM-lO 2940 30034 648 160 -10 2703 3304 Acceptahle 100 80 -~o 0 -10 0 10 0 GO BQ 100

HDL Cholesterol CHM06 8400 85367 3522 98 01 5975 11098 AcccplablemgclL CHM07 7200 72937 32 100 -03 5105 9482 tcceplable CB 20H

RuumlCHE HDL-Cl-luumlL PLUS CHM-08 8400 85597 3639 100 -04 5991 11128 Acceptablc C-A 013

ROCHE fvluumlDUL R CHM-09 10300 105124 5553 98 -04 7358 13667 Acccpt~blc CC 2012

CHM-I0 10700 108070 5059 101 -02 7564 14050 Acccptabic 10080 00 lt0 10 0 10 Q 00 llO 100

hCG serum quant CHM-06 2217 21285 731 297 + 12 1909 2348 AcccptablcmiUmL (IUL) CHM-07 15ar 14494 508 300 + 11 J2-J7 1(02 lcccpllblc Cszlig 201) ~-1-t-iE-_L1__ ]RuumlCllE c600 SEREI70 BE CHM-08 2204 21225 735 299 + 11 190bull 2344 cccltnhlc C-A 2013 n---- -~uiluu-CHM-09 4274 41586 1486 300 +08 3712 4605 Acccptablc c-c 201~

CHMIO 2965 28492 990 29) +12 2552 3147 Acccptnbic -10080 60 ~ -20 0 10 0 60 80 100

Iron CHM-Q6 125 1261 22 124 -05 100 152 AcceplablcIIgdL CHM-Q7 101 106 14 121 -04 81 122 Acceptable CszligOI)

rERRCI--lROlffi Vo PPR CHM-08 125 1262 8 121 -06 100 152 Acceptable Cr OU

RuumlCHE MODULAR CHM-09 195 1982 27 122 -12 158 238 Acccprnblc ce 1012

CHMtO 151 1526 25 124 -06 122 IB4 Accepr~blc 10080 60 lt0 10 0 10 lt0 60 80 00

Ihc CoUcgc of Amcncan Pamologists rtcommcncl mat th feu1t of [his illlerlagtlo) comparioll 1l0 Je cl a a olc enltnn for jlldging the perfonnUlec of am inltidu1dinieallalraory

0001 12365

C-B 2013

Institution IKF laboratorium rur Klinische iorschung cmb[ I

Attention Volker [I-Sama[outi lhD

City State SchTntinllllal C [ 2422)

College or American Pathologists325 Wallk bull~an Rna Northlkl Illinnis 6009327508003234040 bull httpwwwcalor~

Advancing Excellence

EVALUATIONORIGINAL

CAP Numher 72)41)(-111 Kit 1 Kit ID 25522(()

Kit Mailed (32013

Original Evaluation 782111)

Chemistry

Plot of Ihe ReIIive Dislnee of Vom Results fromTargct as Pcrccntagcs of allowcd Dcyiatiol1

TeslUniloflteasmePeer Group

Specimcn

Evalnation and Com larative Ifcthod Statistics

Your NOof Limits of Acceptahility

Result Mean SD Lahs SDI Lower UpperYourGrade Snrvey -100------------ Mean -----------+ 100

Lactate Dehydrogenase

ULI~OCIIE 1[ODUllR

ROClIE37 C

LDL measured

mgt1IROU 11IDI-C [01 PLUS

Lipoprotein(a)

mgt1LNIPIIIU)1[ITRYS[E1[INS

Ilagnesiummmol[

COIoR-DYI~-XYIlDYI BIUI1~()CII 1[ODULtW

CHM-06

CHM-07CHM-08

CHM-09

CHM-IO

CHM-06CHM-07

CHM-08CHM-09

CHM-lO

CHM-06ClIM-07

CHM-08CHM-09

CHM-lO

CHM-06

CHM-07CHM-08

CHM-09CHM-lO

218 2145

148 1447

214 213lt)

205 20 I 401 YJ2

(2110 (8204

5200 5lt)7()

(2IH) 0 I (j()

lnOO I l 5172110 71519

lt2 )

lt23lt2 )

lt23lt2 )

172 17422( 2247172 174(1(2 1(50

1157 1I2(

51 14( +117 171)A 145 +10 1154( 145 00 17

4A 145 +111 I(j()

80 143 + 11 314

425( 44( -15 4778

3A43 444 -23 418342(7 448 -lA 47715871 441 -lA (381

51(8 445 -15 5571

0055 141 -IIA )11

11118 148 +01 1(8

IUWJ 141 -115 1311

01141 147 -11( 12)

111133 151 -17 IIA(

258 lcceptabk

174 cceptabk

257 lcceptabk242 cceptable

472 icceptabk

8875 jcceptabk7770 lcccptable881 fccellabk1185l lcceptabkIOgtA8 cccltabk

1281

1281

1281

1281

1281

218 cceptabk281 tcceptabk211 lcceptabk2117 lccellabk1171 cceptabk

C 21l11

ce 2012

eH 2(1)

c- 2()1

C-C2()12

( - 2flL)

-100 -Si) -lt)0 -4(1 -20 (I 70 40 0 8(1 100

_l_

_1_

Thlt College of i1lKnClll Plthol11lrists nconlllll1lds thaI the nsuIt of tltis i1lltr1abofal(lr~ c()tllparisotl 1lot hl llscd as a sole critlriol1 f(lr jllLiritlgthc pcrfof1nlncl of l1l~illtliiJllll c1illicl1 hhorJt(Jr~

IHIOI 12366 Iage 7 or 15

Kil ID 25522((3

Kil Mailed 632013

Original Evalualion 782013

Kil 1

Institution LKF Laboratorium CurKlinische Forschung Gmbl I

Attention Volker EISamalouti PhD

City State Sehwenulletlta GE 24223

CAP Numher 723413601

IONC-B 2013 Chemistry

Evaluation amI Com arative Method Slatistics Plol oflhe Relative Oistanee ofYom ReslIlls from

Your Noof Limits of Acccptability YOllr Target 36 Pcrccntagcs of aUowcd Deation

S~cimen Result Mean 5D Labs 501 Lower Upper Grade Survcy -IOO--------Mean--------+ 100

CHM-06 52 504 009 173 +18 45 56 AcccptablcCHM-07 63 618 009 172 +14 56 67 Acccptable CU 2013 g-----j=t~mCHM-08 51 sm 008 172 +09 45 SG Acccprabic 1- 2013

CHM-09 53 523 009 173 +08 47 SB Acceprahlece 2012

CHM-IO 22 221 009 171 -(l 17 VI leccptlble 10080 -60 40 20 0 20 0 60 80 100

CHM-06CHM-07 C 201)

CHM-08 C 2013

CHM-09 C-lt2012

CHM-IO -100 -80 -60 -40 -10 0 20 10 dltl 80 100

CHM-6 170 3654 086 174 +05 328 402 IcceprabkCHM-07 330 3273 ORO 17 +0 294 360 AeecltablcCHM-08 370 3658 080 172 +05 329 403 cccptahicCHM-09 470 474) 094 172 -05 427 523 AcceptahleCHM-l0 410 4085 08B 172 +02 167 450 ICCC tableCHM-06 38 1376 14 173 03 133 142 AcceprableCHM-07 141 1425 14 173 +03 138 147 Ieceptable CB ~on

CHM-08 117 1372 13 173 -01 33 142 Acccpta blc CA 2013

CHM-09 152 1514 13 173 +05 147 156 Icceptable C-e 2012

CHM-l0 117 1177 14 171 05 113 122 lcccptablc -100 -80 -(jQ -40 -10 0 10 4Q 60 80 100

gLBIURETROCHE MODULAR

Proteint total serum

TestUnit of f1casurcPeer Group

l-Iclhod Instrument

SOt1iUffit serum

mmolLION SELECT ELECT DILROCHE MODULAR

PotasRium senlmmmolL

ION SELECT ELECT OlLROCHE MODULAR

bull

College of American Pathologistsbull JA 325 Wauhgan Kuall NonhOeld II11noi5 600932750

U flOO)23-i010 huplwwwcRj1org

bull ~~ Advancing Excellence

EVALUAORIGINAL

l11C CollcgC of AmCnCa11 Pnhologists reconUl1cnds dur the resuh o[ chi lnterhhorllory companson nOt bc uscd 5 a sole cnlcrion for judging thC pCrfOnlllnCC of ny indiJual clinical htboruory

0001 12367 Page8t )

Kil ID 25522((3

Kil Mailed 632013

Original Evalualion 782013

Kil 1

Institution LKF Laboratorium CurKlinische Forschung Gmbl I

Attention Volker EISamalouti PhD

City State Sehwenulletlta GE 24223

CAP Numher 723413601

IONC-B 2013 Chemistry

Evaluation amI Com arative Method Slatistics Plol oflhe Relative Oistanee ofYom ReslIlls from

Your Noof Limits of Acccptability YOllr Target 36 Pcrccntagcs of aUowcd Deation

S~cimen Result Mean 5D Labs 501 Lower Upper Grade Survcy -IOO--------Mean--------+ 100

CHM-06 52 504 009 173 +18 45 56 AcccptablcCHM-07 63 618 009 172 +14 56 67 Acccptable CU 2013 g-----j=t~mCHM-08 51 sm 008 172 +09 45 SG Acccprabic 1- 2013

CHM-09 53 523 009 173 +08 47 SB Acceprahlece 2012

CHM-IO 22 221 009 171 -(l 17 VI leccptlble 10080 -60 40 20 0 20 0 60 80 100

CHM-06CHM-07 C 201)

CHM-08 C 2013

CHM-09 C-lt2012

CHM-IO -100 -80 -60 -40 -10 0 20 10 dltl 80 100

CHM-6 170 3654 086 174 +05 328 402 IcceprabkCHM-07 330 3273 ORO 17 +0 294 360 AeecltablcCHM-08 370 3658 080 172 +05 329 403 cccptahicCHM-09 470 474) 094 172 -05 427 523 AcceptahleCHM-l0 410 4085 08B 172 +02 167 450 ICCC tableCHM-06 38 1376 14 173 03 133 142 AcceprableCHM-07 141 1425 14 173 +03 138 147 Ieceptable CB ~on

CHM-08 117 1372 13 173 -01 33 142 Acccpta blc CA 2013

CHM-09 152 1514 13 173 +05 147 156 Icceptable C-e 2012

CHM-l0 117 1177 14 171 05 113 122 lcccptablc -100 -80 -(jQ -40 -10 0 10 4Q 60 80 100

gLBIURETROCHE MODULAR

Proteint total serum

TestUnit of f1casurcPeer Group

l-Iclhod Instrument

SOt1iUffit serum

mmolLION SELECT ELECT DILROCHE MODULAR

PotasRium senlmmmolL

ION SELECT ELECT OlLROCHE MODULAR

bull

College of American Pathologistsbull JA 325 Wauhgan Kuall NonhOeld II11noi5 600932750

U flOO)23-i010 huplwwwcRj1org

bull ~~ Advancing Excellence

EVALUAORIGINAL

l11C CollcgC of AmCnCa11 Pnhologists reconUl1cnds dur the resuh o[ chi lnterhhorllory companson nOt bc uscd 5 a sole cnlcrion for judging thC pCrfOnlllnCC of ny indiJual clinical htboruory

0001 12367 Page8t )

C-B 2013

Institution LKF Lahoratoriulll fur Klinische Iorschung Cl11hll

Attention Volker EI-Samalollti PhD

City State Schwentinental G I~ 2422

College of Amcrican Pathologists325 Wallkegan Iload Northlkld IIlinois 600932750800323-4040 httpwwwcaporg

Advancing Excellence

EVALUATIONORIGINAL

CAP Numher 72H 1(-0 I Kit I Kit ID 25522((J

Kit Mailcd (J)2l1 11

Original Evaluation 7 R20 I

ChemistryTcstUnit ofMcasurcPcer Grollp

Triglycerides

mgdLINZ COLOI~ VoGI) woSII

I~OClII~ IIODULR

Urea Nitrogen

mg LlLURI~iSI fITII CLDIII~OCIIE IlCmUL1R

UreammolIUR 1JS fITII CLDIIROCfII IIODULJR

Uric Acid

mgt1LURICJSE

ROGlE IIODULR

Evaluation and Com arative IIcthod Statistics Plot of the Rclatic Distance of Your ReslIlts from

Vour Noof Limits of Acceptahility VourTarget as Pcrcentag-cs or allowed Deviation

Specimen Reslllt Ilean SD Labs SDI Lower Upper Grade Survey -100------------llean-----------+ 100

CHM-06 U1rll ) U7R57 -127 (7 -15 IlIDlt) 172 1 Jcceptahk

CHM-07 12(JlIO 130(J7lt) -1lt) (7 -lA nlIo I (JD5 cceptabk (-n 201) hCHM-08 IHOO 1)7lt)77 204 (( -12 I(J14R I724R Jcceptabk C-_201)

CHM-09 2021)0 21CJ)25 52)lt) (7 -I(J 15774 2(2lt)1 JcccptabkCC 2012

CHM-IO IIROO 121252 28lt)R (7 -11 lt)lIlt) 15157 Jcceptabk 100 -81 -00 -40 -o 0 70 ll) () )) 100

CHM-06 240 218R 0(lt) 1711 +31 Ilt)R 23lt) ULlcLelIIIk

CHM-07 140 1)7lt) OM 1(lt) +(J) 117 15R Jcceptabk C-B 201) IF T -ICHM-08 220 21RO 0(1 I(JR +CU 1lt)8 2lt) Jcceptabk CA 20L

CHM-09 lt)O 1774 057 I(R +22 157 1lt)R cceptahle(-e 2012

CHIl-lO 450 4gtlt)0 lrn I(JR +10 lt)lt) 47lt) cceptabk -1(111 -80 -11) 4(1 ]0 0 20 -10 ((1 1(11)

x RLsult is outside the acclptablC lilllits

CHM-06 510 7RI 025 170 + 172R 70 R( I JnaLcepuhk

CHM-07 3(JO 4lt)2 02 Im +IOlt)lI 42 57 LIl~(ceptlhlc C-H2()L fHCHM-08 470 7n 022 j(R +17iU 70 R5 I IIllCClpuhlt

CHM-09 41(1 (d 020 I(JR + 1734 5(J 7 LIl1CCCplthlc

CHM-IO 0 15(7 (UR I(R +2114 142 171 LIllCccpllbk -100 80 -uumli) -40 -20 0 20 40 GO 30 100

x Rtsult is ()lltsidl the lcceptlbk litnils

CHM-06 (( (72 011 1(5 -09 55 7lt) Jcccptable

CHM-07 51 512 (Jll 1(5 -02 42 (J() ccept~blc C-B 201 iCHM-08 (( (J72 015 1(5 -OR 55 7lt) Jcceptable C- 201)

CHM-09 29 2 007 I (J1 -0lt) 24 5 cceptlbkCC 21112

CHM-lO 12A 125 02( I (J( -05 I(U 147 Jcceptahk -1(11) -8(1 -(11 -oln -]11 ( 2(1 -1-(1 6f 11 (1Ij

Thc College of At11tIcan Puholltl-r1stsllCOt11tl1ctHIs that thc fCSUlt ()f this itltLrbbocltor~ (OtllPU1S011 llot bl lIstd as a soll cntLlion for judging thc pcrfonnlllcL of al1~ inLiyiLilLd c1inical hhflfltory

(HIlli 12368 Pagelt) of 15

C-B 2013

Institution LKP Lahoratorium fur Klinische Forschung GmhH

Attention Volker EI-Samalouti IhO

City Slate Schwcnlinenlal GE 24223bull

College of American Palhologisls ~A 32~ Waukegan Iload NorthOdd Illinois 60tW)2750

n 800-323--4010 hHplwwwporgbullbull 1 bull

bull Advancing Excellence

EVALUATIONORIGINAL

CA Number 7234136-01 Kit I Kir ID 25522663

Kil Mailcd (3201gt

Original Evaluatioo 782013

Chcmistry

-lOO---------Mcan---------+ 100

10080 OumlO -4020 0 20 40 60 HO 100

rl Z~I

CAOD

c-c 2012

Survey

Plot ofthe Rc1Ile Distce ofYour Restlts poundrumTarget as Perceotages of alloVed Dcaion

YourGrade

AcccplahlcAcccptahlcAcceplableIcceptahlecceptablc

787651ROO

133487G

Mean

2141917403213353417929(4

Evaluation and Comnararive Melhod StatisticsNoof Limits of Acceptability

SO Labs SDI Lower Uppcr

129 07 1905 2378129 -02 1545 1936129 lU IR9 gt 2374129 -1)1 3017 3818129 00 2113 2660

2090173021(034102400

YOltr

ResultSpcdmcn

CHM-06CHM-07CHM-08CHM-09CHM-10

TestUnit ofMeasuPeer Group

Triiodorhyroninc (13)ngdL

RuumlCHE 600 SERE170

T3 freepgmL

ROCHE c(OO SERE170

CHM-06CHM-07CHM-08CHM-09CHM-10

R766R9

IGl105

908697912

15721072

031023034048035

15(

155155153154

-12-16-06

+08-0(

8162ll1

142

96

101 Aeccptahlc77 Acccprahlc

102 Acccprahlc172 AcceprableIIB AcccptabJe

C-R1J13

C 2013

C-ltHZl----[---l-Bfij--I---+-B__________L _1_

I _ I i10080 60 4010 0 20 40 60 80 100

10080 6(] 020 0 20 10 0 80 100

Thyroxine frecngdL

RuumlCHE e600 SERE170

CHM-06CHM-07CHM-08CHM-09CHM-10

2521253828

2462072473270

009

OOB

010019011

gtgt2335331336333

+04+04+03-01

+U9

21lR2133

23

28 Acccptabic24 cceprable21I Acceprable4( Aceeptable31 Aceltptabllt

C-B ~OU

C-A 2013

c-c 2Ol2 111~J--n-~ I iIII~I

I

I

ThyroxineugdL

RuumlCHE e600 SEREI70

CHM-06CHM-07CIIM-08CHM-09CHM-IO

(Ii

5768

1 1175

650546647

1037708

02902502(040027

111IR918BIBB181

+03+10+13+18+ 15

52

4351825(

78 Acccptablc66 Acccplablc78 Acceplable

125 Acccplable85 Icceplabte

C-szlig2011

CAOD

CC20iz

100 -30 -6041) 10 0 10 40 ISO SO 100

Thc College or Arncr1can ParhololrlMS rccolnmcl1d~ hat rhc rcsult ur lhis intCc1ab(lruory cornparison flot bc used ts a sole critcnon (or judging thc pcrfonnancc ur an~ iJ1diidual clinical1boratory

0001 12369

C-B 2013

Institution 111 Iaho[atorillm fur Klinischc 1oc)[SChllllg(mhll

Attention oJkcr El-SamaJollti PhDCity State Schwcntinetltal ( I 21223

College or American Pathologists325 Wallkegall I(oad Norlhlkld IIlinois 600932750800 323-1040 hllpwwweaporg

AdVflllcillg Excellence

EVALUATIONORIGINAL

CAP Numher 72gt4 L(liI Kit I Kit ID 25522((gt

Kit 1Iailell ()20 L

Original Ealuation 720 Igt

Chemistry

TestUnit ofMeasmePeer Grollp

Thyroid Stim Hormone1IIUmL (mIUL)

I~OCIIl c()oO SI-REI70

C02mmollENIYfJTICROCIIl fIODULR

FerritinngmL (llgL)

ROCII E e(()O SEl~ I170

Gamma Glutamyl TransUL

1~()CIll flODULiRROUIE ((j-IFCC37 C

Ealuation and Com aratie 1lethod Statistics Plot of the Helatie Distance of Yom HeslIlts from

Your No of Limits of Acceptability YourTar~ct as Pcrcenta~cs of allued Deviation

Specimen Result 1lean SD Labs SDI Loer Upper Grade Snrey -100------------1 le an -------- ---+ 100

CHM-06 gt35 3340 0070 41 +01 )12 )5( cceltahlcCHM-07 32) ngt5 007gt 41 0( )11 35( cccltahic C-H 2OL) =3CHM-08 )raquo n47 011(7 415 -02 314 )55 Icceptahlc C- 2nl)

CHM-09 771 7)1)2 11177 41( -07 737 844 cccltableCC21112

CHM-IO 114 1157 11025 4U -07 lfm 124 icccltahic -IO) -((1 -(0 -40 -20 lt) (l -In (~f) 80 100

CHM-06 20 14 15 152 +11 L 23 cceptahleCHM-07 )) 212 14 152 +0( 1( 2( cccptabic C-B 2nD FCHM-08 20 I) ) 15 152 +114 14 24 cccltablc C- 201)

~CHM-09 2( 250 15 151 +07 20 30 cceptable ce 2012

CHM-IO 14 121 15 15gt +13 7 17 icclptahlc - 11111 -sn -1(1 _411 _Il ( (1 -11) 11 8c) liin

CHM-06 100 )0) 34 2() +27 0 102 cccltabllCHM-07 ( 7)1 27 2() +2( 71 88 cclptahlc C-B 201)

____1CHM-08 )5 )07 33 2(7 +1 ) U 101 lcceptablc r- 201)

CHM-09 212 2m( 71 2(7 + 12 12 225 cccptahk (-CUL~

CHlI-lO ()C) (1 ) 2( + 18 57 72 lcclltabk -111(1 -80 -Mi -40 -(1 Ci 0 gtIn 6() 3() 100~_)

CHM-06 2 12(11CHM-07 4gt R 12UI

~CHM-08 2 8 12(11 C-- 2O[l

CHlI-09 1 R 12111CC 012

CHM-lO IR4 8 Pli -trUI-(II -r(J -411 -]() 2(1 4(1 1(1 f(r 100

Thc College of jnlCtC~n Pltholog1SS rtCOtllllllIHlS that the fcsuh of this inttrbhoraory CotllPlISOl1 not hc uscd as a sole crircrlo11 fotjudhring t1w pcrfnrnutlcC of at1~-indiyidUJ1 clitlica hborltory_

0(1(11 12370 Page 1I of 15

C-B 2013

Institution 111 Iaho[atorillm fur Klinischc 1oc)[SChllllg(mhll

Attention oJkcr El-SamaJollti PhDCity State Schwcntinetltal ( I 21223

College or American Pathologists325 Wallkegall I(oad Norlhlkld IIlinois 600932750800 323-1040 hllpwwweaporg

AdVflllcillg Excellence

EVALUATIONORIGINAL

CAP Numher 72gt4 L(liI Kit I Kit ID 25522((gt

Kit 1Iailell ()20 L

Original Ealuation 720 Igt

Chemistry

TestUnit ofMeasmePeer Grollp

Thyroid Stim Hormone1IIUmL (mIUL)

I~OCIIl c()oO SI-REI70

C02mmollENIYfJTICROCIIl fIODULR

FerritinngmL (llgL)

ROCII E e(()O SEl~ I170

Gamma Glutamyl TransUL

1~()CIll flODULiRROUIE ((j-IFCC37 C

Ealuation and Com aratie 1lethod Statistics Plot of the Helatie Distance of Yom HeslIlts from

Your No of Limits of Acceptability YourTar~ct as Pcrcenta~cs of allued Deviation

Specimen Result 1lean SD Labs SDI Loer Upper Grade Snrey -100------------1 le an -------- ---+ 100

CHM-06 gt35 3340 0070 41 +01 )12 )5( cceltahlcCHM-07 32) ngt5 007gt 41 0( )11 35( cccltahic C-H 2OL) =3CHM-08 )raquo n47 011(7 415 -02 314 )55 Icceptahlc C- 2nl)

CHM-09 771 7)1)2 11177 41( -07 737 844 cccltableCC21112

CHM-IO 114 1157 11025 4U -07 lfm 124 icccltahic -IO) -((1 -(0 -40 -20 lt) (l -In (~f) 80 100

CHM-06 20 14 15 152 +11 L 23 cceptahleCHM-07 )) 212 14 152 +0( 1( 2( cccptabic C-B 2nD FCHM-08 20 I) ) 15 152 +114 14 24 cccltablc C- 201)

~CHM-09 2( 250 15 151 +07 20 30 cceptable ce 2012

CHM-IO 14 121 15 15gt +13 7 17 icclptahlc - 11111 -sn -1(1 _411 _Il ( (1 -11) 11 8c) liin

CHM-06 100 )0) 34 2() +27 0 102 cccltabllCHM-07 ( 7)1 27 2() +2( 71 88 cclptahlc C-B 201)

____1CHM-08 )5 )07 33 2(7 +1 ) U 101 lcceptablc r- 201)

CHM-09 212 2m( 71 2(7 + 12 12 225 cccptahk (-CUL~

CHlI-lO ()C) (1 ) 2( + 18 57 72 lcclltabk -111(1 -80 -Mi -40 -(1 Ci 0 gtIn 6() 3() 100~_)

CHM-06 2 12(11CHM-07 4gt R 12UI

~CHM-08 2 8 12(11 C-- 2O[l

CHlI-09 1 R 12111CC 012

CHM-lO IR4 8 Pli -trUI-(II -r(J -411 -]() 2(1 4(1 1(1 f(r 100

Thc College of jnlCtC~n Pltholog1SS rtCOtllllllIHlS that the fcsuh of this inttrbhoraory CotllPlISOl1 not hc uscd as a sole crircrlo11 fotjudhring t1w pcrfnrnutlcC of at1~-indiyidUJ1 clitlica hborltory_

0(1(11 12370 Page 1I of 15

bull Colleg or Ambullbullan Patholog CAP Number 7234136-01 Kit 1 Kit ID 25522(63bullbull ~ 325 WukcRn RodNonhflcld IIlinois 60093-2750 Institution LKr L~bor~torium fur Klinische Forschung GmbH Kil Mailed 632013

bull BOO-323-+(40 hllpfwwwclorgbull~ Auenlioo Volk er El-S~m~lotllj PhD Original Evaluation 782013 Advancing Excellence City Stale SchwentimlIlU GE 24223

EVALUATIONC-B 2013 Chemistry

ORIGINALTet Evaluation aod Comnaralive Method Statlstics Plot of thc Relative Dislance of Yom Rcsuhs from

Unit ofMeasure Noof Limits of Acceplability YourTarget as Percentages of alloved Deviation

Peer Group VourSpeeimen Re8ult Mean SD Lah bullbull SDI Lower Upper Grade SUITey -100-----------Mean-----------+ 100

Lipase CHM-06 36 350 20 132 +05 24 46 Acccptablc

UL CIIM-07 35 322 19 133 +15 22 42 tcceptable cn 20n ~l~=f~~~[jRuumlCHE MODULAR CHM-08 36 151 20 131 +05 24 46 lcccptahlc C- 2013

ROCI-IE37 C CHM-09 74 7Ul 44 130 +05 50 lt)4 tcccptahicCC21112

CHM-I0 25 243 13 129 +06 16 32 Acccptahle -100 80 -60 -20 0 20 0 60 30 100

Pancrltatic Amylase CHM-06 57 631 11 26 -54 44 n Acccptahlc

UL CHM-07 35 330 07 26 +21 23 43 icccplabk C-B 201) ffiHIIIIJ-_- _ _~-_bullbull ----- - - -- - - - _ -

RuumlCHE MODULAR CHM-08 S9 633 10 2( -44 44 83 Icccplabic CA 201 -- --+- _-1_ ---t--- --+-------ROCHE37C CHM-09 4( 483 09 26 -26 33 (3 icccplablc c-c 2012

CHM-l0 141 1447 2U 26 -19 101 189 ACCcplble -100-80 -00 -40 -10 0 20 0 00 80 100

Phosphorus serum CHM06 131 1359 0039 159 -13 121 151 icccptablcmmolL CHM-07 1(7 1709 0043 161 -09 152 1lt)0 Acccptablc cn 2(1)

x 6~=j~-1~=HPHOSPHOMOL YBD1TE UV CHM-08 134 1358 0040 1(2 -05 121 151 lcccplable C-AZOt

RuumlCHE MODULAR CHM-09 111 1127 0039 159 -04 118 147 Jcccprabicce 2012

CHM-I0 045 0484 0O2~ 161 -12 038 059 1cceplable -100 -80 -vO -40 20 0 20 lt0 00 80 teO

x Rtsult is outside thc ~cClptablC Iitrues

Iron Bioding Ca P lot CHM-06 175 120JIIgdl CHM-07 154 12deg1

TURBID IMETRC IMMUNUru R CHM-08 173 120JSIEMENS NEPIJELOMETR SY CHM-09 220 12deg1

CHM-I0 197 IZOI

nIe College of jmcdCn Pathol()gi~lg rccOInmcllds thH thc rcslllt of lhi illlCrhho(fory compiuison not bc l~cd ~s a sole enrerioH fuumlr judgillg (he pCrr()nlUnCC of my individutl cEnical tlbucl(ory

0001 12371 Page L v 15

C-B 2013

Institution IKF laboratorium fur 1litliscile orscilullg Cmbll

Attention Volker 1ISamalouli Ph])

City State SchWl1lillclltal C I~ 2422

College or American Pathologists325 Wallkegan Rnad Northfield IIlinnis 60092750800323 H140 bull htlpwwwcalorg

Advancing Excellence

EVALUATIONORIGINAL

CAP Numher 7241)(01 Kit I Kit ID 25522((

Kit Mailed ()201)

Original Evaluation 7X2111)

ChemistryTest Evaluation and Com arative Method Statistics PIt fthe Relative Distance fYom Reslllts fromUnit f lteasure

Vour Noof Limits of Acceptahility VourTar~ct as Pcrcentagcs uf allowcu Dciation

Peer GroupSpecimen Result 1lean SD Labs SDl Lower Upper Grade Surcy -100------------1 kan -----------+ 100

Transfcrrin CHM-06 12400 12(39 7027 (gtI -0 ) 10111 15 I (X cccpllble

mg dl CHM-07 10900 114XX5 (5X I 61 -09 9 I 91I 1)7X7 lcccptlbk- C-B ~O1 3SIIIIENS NIPIIEIOMITR SY CIIM-OS 12300 12(017 (X49 59 -04 100XI 1512 cceptabk- C-_~lJU

CH1I-09 15(00 1(2(3) 9072 (1 -07 1)011 19517 lcceptlblc C 21112

CHM-1O 14000 13X525 7XOI (1 +112 IIOXI 1((23 lcccptabk- -100 -81) -00 _( -20 U 20 40 1 30 100

11ll Colleglt of ll1Cl1Cln Patl1010hrists fCCOllltl1lIHlS that thc flsult of Ihis intLrbboralory cotnpariSoll not be lIsnl JS a solL critCtOll for jud-ng hc )1crfonnancc of 11l~indiidual clinictilaboLlt(r~-

11001 12372 Pagc 13 of 15

C-B 2013

Institution LKl~ L~bortOlillm fur Klinische Forschung GmbH

Attenlion Volkcr E1-Samlollri PhD

City j State Schwenrincnla GE 24223bull

College of American Pathologist5 f~ 325 lUkeKn Roc1 Nonhrocld Iliinols 600932750

Ui bull 800-31gt-~040 hllpwwwcapor~

- Advancing Excellence

EVALUATIONORIGINAL

CAP Number 72413()01 Kit 1 Kit ID 25522(6)

Kit Mailed (32013

Original Evaluation 7jRj20 13

Chcmistry

CAPCAP 723416 Sulgtspecialty Ruulinc ChcmislIY

Proficiency Event Proficiency Event Proficiency Evenl

2012 3 2013 1 2013 2 Currenl Evcnl Cumullive CLIAPerfoml 111 ce 88 Performance

Relulated Analvte TeSI Evenl Score Tesl Evenl Score Tcst Evenl Score Intemrelation Intcmrelalion

ALT CC 55 100 (- 55 100 C-B 55 100 SJti~f~ctory Successful

Alhumin (-e 55 100 (- 55 100 C-szlig 55 100 StisfctorY Succes~ful

Alkaline Phosphate CC 55 100 c- 55 100 C-B 55 100 Stisfactory SuccefuJ

Amylae (-( 55 IOD C- 55 100 C-B 55 100 Salis fac tory Succcssful

oe

AST CC 55 100 (- 55 100 C-szlig 55 100 Sausfctory Successful

Bilirubin TOI1 (-c 55 100 C-I 55 100 C-Il 55 100 Satisfcrory Sllcrc~sfulCalcium Total C-C 55 100 C- 55 100 C-B 55 WO Satisfclcgtry Succcssful

Chloride CC 55 100 CA 55 100 C-Il 55 100 Slti~flctory Succltssful

CboleBterol Total C-C 55 100 C-A 55 100 C-B 55 I()(l Sa tis [c Irgtry Succeful

Choleslerol HDL C-C 55 100 C-A 55 100 C-szlig 55 100 StisEcltgtr Succcssful- bullbull _

_ Creatirte Kinase C-C 55 100 C- 55 100 C-B 55 100 Sa tisfctrry SucccssfuJCK Isoenzymes (eie-MB) CARC 55 100 CAR-l 55 100 CAR-fl 55 100 S~tisritcrory Succcful

Ceatil1ine _ 1- - - -C-C 55 100 C-1 55 100 C-Il 55 100 StisEcltgtry Succcssful

Glucose C-C 55 100 C-A 55 100 (-B 55 100 Stti~(lcrory Succcssful bull~ SatisfcioryIron TOlal

ce 55 100 C- 55 100 C-Il 55 100 Successful

LD c-c 55 100 C- 55 100 C-Il 55 Ion Susfcmr $uccrssful- - 55 55 StisfctoryMagneium c-c 100 C-1 55 100 C-B 100 Succcssful~

Pot3ssium C-C 55 100 C-1 55 100 C-1I 55 100 St1isfactory Successfn]

Sodium_ C-C 55 100 C-A 55 100 C-szlig 55 100 Satisfctory Successfu bull r bull ~~ - _l bullbull

Protdn Total C-C 55 100 (-A 55 100 C-ll 55 100 Susfcror SncccssEu

Triglyceri~ C-C 55 100 CA 55 100 C-szlig 55 100 Satisfctory Succltssfu

Urea Nitrogen C-C 55 100 C- 55 100 C-Il 45 RO Sausfctory Sllcclssful

Une Acid C-C 55 100 C-A 55 100 C-szlig 55 100 Satisfcrory Succes$ful

Jhe Collcg-e of AmcnclJl Pathologists recolnrnends Ihat thc rCsuh of this lnrcrbborafOry companson not be l1SCU as l ~olc ccitcnon ror judging the pltrfonnncc of any inJiddud clinicalla1xJrutlt

0001 12373 lg 11 v bullbull 5

C-B 2013

Institution IKI Iaboratorium fur Klinische Jiorschung (l11bll

Attention Volker El-Samalouti PhI)

City State Schentinental CE 2422)

College of Amcrican Pathologisls325 WnkWlIl Road Nonhlkld Illinois 60093-2750800-323-4040 hltpwwcapori

Advancing Excellence

EVALUATIONORIGINAL

CAP Numher 72)4130-01 Kit 1 Kit ID 25522(0)

Kit Mailed 0)21IU

Original Evaluation 7X20 13

Chemistry

CAP

CAP 72)4150 Suhspecialty Routine ChemisllT

Proficieney Event Proficieney Event Proficiency Event

2012 ) 21lU 1 20) 2 Current Eveut Cumulative CLIAPerformance 88 Performance

Reulated Ana1vte Test Event Score (Yo Test Event Score 00 Test Event Score l~) Interpretation Interllretation

Routine Chemistry 115115 100 115115 100 114115 99 Satisfactory Successful

Thc College of Itlllncan PatholohJ1sts tlCOtlllllllHIS dut thc fcsul of Ihis illtlrbboratory clltnplfis()l1 not Je llSld lS a solL critcrl0t1 for jutihrlng he pcrfOrtlUllCl of allY indiidud clinical hhoclory

(111111 12374 Page 15 o[ 15

• 00000001
• 00000002
• 00000003
• 00000004
• 00000005
• 00000006
• 00000007
• 00000008
• 00000009
• 00000010
• 00000011
• 00000012
• 00000013
• 00000014
• 00000015

C-B 2013

Institution IKI Iaboratorium fur Klinische Jiorschung (l11bll

Attention Volker El-Samalouti PhI)

City State Schentinental CE 2422)

College of Amcrican Pathologisls325 WnkWlIl Road Nonhlkld Illinois 60093-2750800-323-4040 hltpwwcapori

Advancing Excellence

EVALUATIONORIGINAL

CAP Numher 72)4130-01 Kit 1 Kit ID 25522(0)

Kit Mailed 0)21IU

Original Evaluation 7X20 13

Chemistry

CAP

CAP 72)4150 Suhspecialty Routine ChemisllT

Proficieney Event Proficieney Event Proficiency Event

2012 ) 21lU 1 20) 2 Current Eveut Cumulative CLIAPerformance 88 Performance

Reulated Ana1vte Test Event Score (Yo Test Event Score 00 Test Event Score l~) Interpretation Interllretation

Routine Chemistry 115115 100 115115 100 114115 99 Satisfactory Successful

Thc College of Itlllncan PatholohJ1sts tlCOtlllllllHIS dut thc fcsul of Ihis illtlrbboratory clltnplfis()l1 not Je llSld lS a solL critcrl0t1 for jutihrlng he pcrfOrtlUllCl of allY indiidud clinical hhoclory

(111111 12374 Page 15 o[ 15

• 00000001
• 00000002
• 00000003
• 00000004
• 00000005
• 00000006
• 00000007
• 00000008
• 00000009
• 00000010
• 00000011
• 00000012
• 00000013
• 00000014
• 00000015